2. FINE-ONE: Finerenone Proves Benefit in Type 1 Diabetes and CKD
Finerenone produced a 25% relative reduction in UACR over 6 months versus placebo in adults with type 1 diabetes and chronic kidney disease, meeting the primary endpoint of the…